In this Common Cents segment we discuss the growing demand for GLP-1 medications and why investors may want to look beyond the biggest drugmakers to the full healthcare ecosystem, including medical devices, manufacturing, distribution, and administration
Individual results vary based on starting weight, lifestyle factors, adherence to diet and exercise recommendations, genetic factors, and how each person's body responds to the medication
While no evidence shows that GLP-1s disrupt thyroid hormone levels, patients on thyroid medication should still monitor TSH, free thyroxine (Free T4), and free triiodothyronine (free T3) every 6 to 8 weeks when starting or adjusting therapy
(Gallstones can also result from rapid weight loss in the absence of GLP-1 medication.) Thyroid tumors: Animal studies have raised concerns about a potential link between GLP-1s and thyroid tumors, but ongoing surveillance has not shown that this applies to humans
& Ryu, H.-Y
Injection timing and technique Semaglutide is administered as a subcutaneous injection, typically in the abdomen, thigh, or upper arm